Class II · Moderate risk
BUP 10MG/HYDROM 15MG/SUF 200MCG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
BUP 10MG/HYDROM 10MG/MORP 2MG/SUF 250MCG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BUP 10MG/ FENT 1000MCG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BPC-157 2000 mcg/mL in 5 mL vials Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
Bi-Mix Forte 30 mg/2 mg/mL Inj. in 1 mL vials Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
Bi-Mix 30 mg/1 mg/mL Inj. in 1 mL vials Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
Baclofen 2000mcg/Ml
Lack of sterility assurance.
Class II · Moderate risk
BAC 800MCG/BUP 6.7MG/CLON 600 MCG/FENT 850MCG/MORP 20MG INJ in…
Lack of sterility assurance.
Class II · Moderate risk
BAC 50MCG/ HYDROM 10MG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 400MCG/BUP 20MG/HYDROM 15MG/SUF 1000MCG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 4000MCG /FENT 600MCG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 250MCG/ /FENT 3500MCG/ /MORP 25MG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 2400MCG/ FENT 2600MCG/ MORP 3600MCG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 225MCG/ BUP 4.5MG/ CLON 9MCG/ MORP 3MG/ML ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 200MCG/BUP22MG/CLON210MCG/HYDROM 15MG/SUF800MCG/ML ML INJ in…
Lack of sterility assurance.
Class II · Moderate risk
BAC 200MCG/ CLONI 250MCG/ MORP 10MG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 160MCG/HYDROM 16MG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 15MCG/HYDROM 15MG/ML INJ in 20 mL syringe Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
BAC 150 mcg/BUP 2 mg/Hydrom 15 mg/Morp 20 mg/SUF 650 mcg/mL Inj…
Lack of sterility assurance.
Class II · Moderate risk
Autologous Serum 20% Eye Drops in 3 mL droppers Assurance Infusion
Lack of sterility assurance.
Class II · Moderate risk
Alprostadil 40 mcg/mL
Lack of sterility assurance.
Class III · Low risk
PCA Skin Blemish Control Bar
Superpotent Drug: Salicylic acid content is above the firm's specification.
Class II · Moderate risk
Testosterone Topical Cream 4%
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Class II · Moderate risk
Tadalafil 6 mg Capsule
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Class II · Moderate risk
Tadalafil 20 mg Troche
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.